#Clinical Trials
Articles tagged "Clinical Trials"
Roche's CT-388 Achieves 22.5% Weight Loss in Phase 2 Trial
Roche's investigational obesity drug CT-388 demonstrated 22.5% placebo-adjusted weight loss at 48 weeks in Phase 2 trial, advancing to Phase 3 studies.
New Ingestible Capsule Offers Drug-Free Solution for Weight Management
FDA-cleared Epitomee capsule offers drug-free weight loss for BMI 25-40 adults. This ingestible device expands in the stomach to promote fullness without medications.